South Korean Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Samsung Epis Holdings

Market Cap: ₩8.9t

A biotechnology company, manage the portfolio of biopharmaceutical products.

SK Biopharmaceuticals

Market Cap: ₩6.6t

A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.

ST PharmLtd

Market Cap: ₩2.1t

Provides manufacturing services for active pharmaceutical ingredient and intermediate.

Aimed Bio

Market Cap: ₩1.6t

Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.

Seegene

Market Cap: ₩1.4t

Manufactures and sells molecular diagnostics products worldwide.

DongKook Pharmaceutical

Market Cap: ₩801.6b

Produces and sells pharmaceutical products in South Korea and internationally.

Myung In Pharmaceutical

Market Cap: ₩662.8b

A pharmaceutical company, manufactures ETC and OTC drugs.

BioNote

Market Cap: ₩489.3b

Manufactures and sells in-vitro diagnostic animal medicines in South Korea.

Medy-Tox

Market Cap: ₩439.3b

Operates as a biopharmaceutical company in South Korea.

NIBEC

Market Cap: ₩189.7b

A healthcare company, engages in the manufacture and sale of dental bone grafts and tissue regenerative collagen products in South Korea and internationally.

Hana Pharm

Market Cap: ₩149.5b

Develops and provides various pharmaceutical products in South Korea and internationally.

Curiosis

Market Cap: ₩145.7b

Develops, produces, and supplies laboratory equipment in the field of life science.

Sam-A Pharm

Market Cap: ₩83.6b

Operates as a pharmaceutical company in South Korea.

BIO-FD&CLtd

Market Cap: ₩75.7b

Develops active ingredients for anti-aging cosmetics in South Korea.

P&K Skin Research Center

Market Cap: ₩55.3b

Engages in the evaluation and research of dermatological products in South Korea.